Cellular and Humoral Immune Responses after 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant
Research output: Contribution to journal › Letter › Contributed › peer-review
Contributors
Details
Original language | English |
---|---|
Pages (from-to) | E267-E269 |
Journal | Transplantation |
Volume | 105 |
Issue number | 11 |
Publication status | Published - 1 Nov 2021 |
Peer-reviewed | Yes |
External IDs
PubMed | 34342963 |
---|---|
ORCID | /0000-0003-2739-345X/work/142239599 |
ORCID | /0000-0002-1507-8009/work/142241672 |
ORCID | /0000-0002-9728-1413/work/145699140 |
ORCID | /0000-0003-1875-273X/work/175220416 |
ORCID | /0000-0002-8059-4368/work/175220649 |
PubMedCentral | PMC8549130 |
Keywords
Sustainable Development Goals
ASJC Scopus subject areas
Keywords
- Adult, Aged, Antibodies, Viral/blood, BNT162 Vaccine, COVID-19/immunology, COVID-19 Vaccines/administration & dosage, Female, Graft Rejection/immunology, Humans, Immunity, Cellular/drug effects, Immunity, Humoral/drug effects, Immunization, Secondary/statistics & numerical data, Immunosuppressive Agents/administration & dosage, Kidney Transplantation/adverse effects, Male, Middle Aged, SARS-CoV-2/immunology, Transplant Recipients/statistics & numerical data